Microplate Assays for in Vitro Evaluation of Anti‐<i>Pneumocystis</i> Drugs.
Esperanza Herreros(GlaxoSmithKline (Spain)), Domingo Gargallo‐Viola(GlaxoSmithKline (United Kingdom)), El Moukhtar Aliouat(Inserm), María Jesús Almela, Sonia Lozano(GlaxoSmithKline (United Kingdom)), HELLEN JACKSON(Wellcome Trust), MIREYA MARTINEZ
Cited by 5
Related Papers
Improved Murine Model of Malaria Using<i>Plasmodium falciparum</i>Competent Strains and Non-Myelodepleted NOD-<i>scid IL2R</i>γ<sup><i>null</i></sup>Mice Engrafted with Human Erythrocytes
|Antimicrobial Agents and Chemotherapy|2009|189
A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes
|PLoS ONE|2008|164
Synthesis and Structure–Activity Relationships of 4-Pyridones as Potential Antimalarials
|Journal of Medicinal Chemistry|2008|139
Transmission of Pneumocystis carinii Disease from Immunocompetent Contacts of Infected Hosts to Susceptible Hosts
|European Journal of Clinical Microbiology & Infectious Diseases|2000|134
Anticoagulants Interfere with PCR Used To Diagnose Invasive Aspergillosis
|Journal of Clinical Microbiology|2002|122